0 Item(s)
The Neuropsychology (Broadly Conceived) of MSA, PSP, and CBD
Non Member ($50.00) Member ($30.00)
Buy Now
Credit
CE:1.5
Description
The Neuropsychology (Broadly Conceived) of MSA, PSP, and CBD
The primary objective of this presentation will be to review the cognitive and behavioral features of the different atypical parkinsonian syndromes in which motor symptoms dominate early clinical symptomatology: multiple systems atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD). The impact of cognitive and behavioral deficits on quality of life, associations between neuropsychological and neuropsychiatric findings and brain imaging, and cognitive and behavioral symptom management are also discussed. Information included in this presentation was acquired through review of the available MSA, PSP, and CBD literature, with emphasis given to studies investigating the cognitive and behavioral features of the syndromes.
The primary objective of this presentation will be to review the cognitive and behavioral features of the different atypical parkinsonian syndromes in which motor symptoms dominate early clinical symptomatology: multiple systems atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD). The impact of cognitive and behavioral deficits on quality of life, associations between neuropsychological and neuropsychiatric findings and brain imaging, and cognitive and behavioral symptom management are also discussed. Information included in this presentation was acquired through review of the available MSA, PSP, and CBD literature, with emphasis given to studies investigating the cognitive and behavioral features of the syndromes.
After the webinar, participants will be able to:
- Describe the neuropsychological features of MSA, PSP, and CBD.
- Explain the impact of neuropsychological features on quality of life in MSA, PSP, and CBD.
- Describe the current strategies for symptom management in MSA, PSP, and CBD.
Instructional Level: Intermediate